Published in Enferm Infecc Microbiol Clin on January 01, 2005
[For whom the bell tolls]. Enferm Infecc Microbiol Clin (2007) 1.96
The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide, is protective in two murine models of colitis. Eur J Pharmacol (2003) 1.48
Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer (2002) 1.44
The lifestyle of Corynebacterium urealyticum derived from its complete genome sequence established by pyrosequencing. J Biotechnol (2008) 1.40
Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strains. Microb Pathog (2008) 1.13
Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations. Eur J Hum Genet (2003) 1.02
Biofilm formation as a novel phenotypic feature of adherent-invasive Escherichia coli (AIEC). BMC Microbiol (2009) 1.01
Antimicrobial susceptibility of Streptococcus pyogenes in Central, Eastern, and Baltic European Countries, 2005 to 2006: the cefditoren surveillance program. Diagn Microbiol Infect Dis (2009) 0.99
Biofilm formation by Streptococcus pneumoniae strains and effects of human serum albumin, ibuprofen, N-acetyl-l-cysteine, amoxicillin, erythromycin, and levofloxacin. Diagn Microbiol Infect Dis (2010) 0.97
Correlation between rating scales and sleep laboratory measurements in restless legs syndrome. Sleep Med (2004) 0.97
Local and systemic effects of hypertonic solution (NaCl 7.5%) in experimental acute pancreatitis. Pancreas (2006) 0.88
Increased prevalence of p53 overexpression from typical endometriosis to atypical endometriosis and ovarian cancer associated with endometriosis. Eur J Obstet Gynecol Reprod Biol (2004) 0.86
The impact of medical therapy on surgery for benign prostatic hyperplasia: a study comparing changes in a decade (1992-2002). BJU Int (2005) 0.86
The efficacy and safety of oral pharmacokinetically enhanced amoxycillin-clavulanate 2000/125 mg, twice daily, versus oral amoxycillin-clavulanate 1000/125 mg, three times daily, for the treatment of bacterial community-acquired pneumonia in adults. Int J Antimicrob Agents (2002) 0.85
Optimal dose of amoxicillin in treatment of otitis media caused by a penicillin-resistant pneumococcus strain in the gerbil model. Antimicrob Agents Chemother (2002) 0.84
Circadian variation in neuroendocrine response to L-dopa in patients with restless legs syndrome. Sleep (2004) 0.84
In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. J Antimicrob Chemother (2007) 0.84
Complete Genome Sequence of Corynebacterium urealyticum Strain DSM 7111, Isolated from a 9-Year-Old Patient with Alkaline-Encrusted Cystitis. Genome Announc (2013) 0.83
Pneumococcal LytA autolysin, a potent therapeutic agent in experimental peritonitis-sepsis caused by highly beta-lactam-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (2007) 0.82
Hypertonic saline and reduced peroxynitrite formation in experimental pancreatitis. Clinics (Sao Paulo) (2011) 0.81
Adherence of Streptococcus pneumoniae to polystyrene plates, effect of serum on adhesion, and virulence in the gerbil otitis media model. Microb Pathog (2007) 0.81
Observation of microcolonies on Middlebrook 7H11 medium for rapid detection of Mycobacterium tuberculosis and the Mycobacterium avium complex in clinical samples. Clin Microbiol Infect (1996) 0.80
Comment on: Functional relationship between bacterial cell density and the efficacy of antibiotics. J Antimicrob Chemother (2009) 0.80
Effect of antibiotic treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae strains with different susceptibilities to amoxicillin. Antimicrob Agents Chemother (2004) 0.79
Adherence of Streptococcus pneumoniae to polystyrene plates and epithelial cells and the antiadhesive potential of albumin and xylitol. Pediatr Res (2011) 0.79
Infection caused by Ochrobactrum anthropi. Clin Microbiol Infect (1996) 0.79
Antimicrobial susceptibility of multidrug-resistant Streptococcus pneumoniae strains with penicillin MICs of 8 to 32 mg/L. Diagn Microbiol Infect Dis (2009) 0.79
Circadian effects of dopaminergic treatment in restless legs syndrome. Sleep Med (2004) 0.78
Does fluid hysteroscopy increase the stage or worsen the prognosis in patients with endometrial cancer? A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol (2004) 0.77
Positive end-expiratory pressure and renal function influence B-type natriuretic peptide in patients with severe sepsis and septic shock. Arq Bras Cardiol (2008) 0.77
Correlation between in vitro and in vivo activity of levofloxacin and moxifloxacin against pneumococcal strains with different susceptibilities to fluoroquinolones. Int J Antimicrob Agents (2006) 0.76
Effect of erythromycin treatment delay on therapeutic outcome of experimental acute otitis media caused by Streptococcus pneumoniae. J Antimicrob Chemother (2005) 0.76
[Corynebacterium urealyticum: from the bedside to complete genome sequence]. Enferm Infecc Microbiol Clin (2009) 0.76
[Pharmacodynamic parameters to evaluate antibiotic cover as empirical treatment]. Enferm Infecc Microbiol Clin (2011) 0.75
Pulmonary damage and bacterial load in assessment of the efficacy of simulated human treatment-like amoxicillin (2,000 milligrams) therapy of experimental pneumococcal pneumonia caused by strains for which amoxicillin MICs differ. Antimicrob Agents Chemother (2005) 0.75
Antibiotic prophylaxis for hernia repair. J Am Coll Surg (2006) 0.75
Impact of ibuprofen therapy in the outcome of experimental pneumococcal acute otitis media treated with amoxicillin or erythromycin. Pediatr Res (2006) 0.75
In vivo activity of amoxicillin/clavulanic acid and erythromycin in experimental otitis media caused by Streptococcus pneumoniae plus Haemophilus influenzae. Int J Antimicrob Agents (2004) 0.75
Is it possible to achieve bacterial eradication in otitis media with effusion by empirical antibiotic high doses and concomitant administration of acetaminophen? A microbiological and pharmacological study in the gerbil model. Int J Antimicrob Agents (2003) 0.75
[Infections of the urinary tract caused by permanent catheterization. Natural history, infective mechanisms and prevention strategies. An overall review based on our clinical experience and research]. Arch Esp Urol (2007) 0.75
Optimal co-amoxiclav ratios for inhibiting Escherichia coli strains with different susceptibilities to the compounds. Int J Antimicrob Agents (2005) 0.75
Efficacy of cefminox compared with amoxicillin/clavulanic acid as a single dose for the prevention of intra-abdominal sepsis in mice intraperitoneally infected with different strains of Escherichia coli and one strain of Bacteroides fragilis. Int J Antimicrob Agents (2006) 0.75
Does acetaminophen interfere in the antibiotic treatment of acute otitis media caused by a penicillin-resistant pneumococcus strain? A gerbil model. Pediatr Res (2003) 0.75
Comparative efficacy of novobiocin and amoxicillin in experimental sepsis caused by beta-lactam-susceptible and highly resistant pneumococci. Int J Antimicrob Agents (2010) 0.75
Urine bactericidal activity after administration of gemifloxacin and trovafloxacin single doses in a phase I study. Int J Antimicrob Agents (2002) 0.75